Injective Price Breakout Triggers Debate Over Shrinking Supply

Injective's price has surged nearly 10% after breaking out of a weeks-long downtrend, sparking debate over its shrinking supply compared to Bitcoin's hard cap.

The project's team stirred up controversy by comparing INJ's declining supply to BTC's fixed 21 million supply, arguing that if fee burn outpaces new issuance, INJ becomes more scarce than BTC.

However, CoinGabbar could not independently verify the underlying math behind this claim, and it remains a topic of debate among traders and analysts.

Market data shows that Injective's price has been trending upwards, with a 24-hour trading volume of $89.25 million and a market capitalization of $557.69 million.